LEI 967600XOEQGS2DP68296
PaterGrus
Contract awards & public grants
Proof of Principle of the best-in-class therapeutic mRNA cancer vaccine → PATERGRUS BVBA
European Commission · BE · Grant · 2021-02-15
€221,813
Personalised Treatment For Cystic Fibrosis Patients With Ultra-rare CFTR Mutations (and beyond) → PATERGRUS BVBA
European Commission · BE · Grant · 2017-11-28
€302,075
SUpport and PartnERship for the development of multiple sustainable and market ready value chains in the BIObased economy → PATERGRUS BVBA
European Commission · BE · Grant · 2016-06-20
€84,163
Clinical Proof of concept for a RNA-targeting Oligonucleotide for a Cystic fibrosis-F508del MEDication → PATERGRUS BVBA
European Commission · BE · Grant · 2015-04-21
€330,085
Entity identity is matched from published recipient names and registry IDs to GLEIF legal-entity records; matches can be imperfect. Source records are public procurement and grant notices.